An HPLC method for the measurement of 5-fluorouracil in human plasma with a low detection limit and a high extraction yield

M A Nassim(Ottawa Regional Cancer Foundation), Rakesh Goel(Ottawa Hospital), Diedre Redmond, Farshad H. Shirazi(Shahid Beheshti University of Medical Sciences), M. Molepo, C. Cripps(Canadian Partnership Against Cancer), S Veerasinghan, Mihail Obrocea(AstraZeneca (Japan)), Diane Fry, David J. Stewart, Susan E. Bates(The Nature Conservancy)
International Journal of Molecular Medicine
October 1, 2002
10.3892/ijmm.10.4.513
Cited by 27

Related Papers

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.9k
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2023|1.1k
From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance
|Cellular and Molecular Life Sciences|2001|685
Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations.
|PubMed|1996|388
PANCREOX: A Randomized Phase III Study of Fluorouracil/Leucovorin With or Without Oxaliplatin for Second-Line Advanced Pancreatic Cancer in Patients Who Have Received Gemcitabine-Based Chemotherapy
|Journal of Clinical Oncology|2016|291